메뉴 건너뛰기




Volumn 101, Issue 6, 2008, Pages 606-611

Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive

Author keywords

Aspirin; Cardiovascular disease; Coronary artery disease; Diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; GLYCOSYLATED HEMOGLOBIN;

EID: 45149122775     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318173316c     Document Type: Article
Times cited : (3)

References (8)
  • 1
    • 67650316726 scopus 로고    scopus 로고
    • Standards of Medical Care in Diabetics-2006. American Diabetes Association. Diabetes Care 2006;29:S4-S42.
    • Standards of Medical Care in Diabetics-2006. American Diabetes Association. Diabetes Care 2006;29:S4-S42.
  • 2
    • 0034859260 scopus 로고    scopus 로고
    • Comprehensive management of patients with type 2 diabetes: Establishing priorities of care
    • David KM, Richard BM. Comprehensive management of patients with type 2 diabetes: establishing priorities of care. Am J Manag Care 2001; 7(suppl):S327-S343.
    • (2001) Am J Manag Care , vol.7 , Issue.SUPPL.
    • David, K.M.1    Richard, B.M.2
  • 3
    • 10244255043 scopus 로고    scopus 로고
    • Changing aspirin use in patients with type 2 diabetes in the UKPDS
    • Cull CA, Neil HAW, Holman RR. Changing aspirin use in patients with type 2 diabetes in the UKPDS. Diabet Med 2004;21:1368-1371.
    • (2004) Diabet Med , vol.21 , pp. 1368-1371
    • Cull, C.A.1    Neil, H.A.W.2    Holman, R.R.3
  • 4
    • 1842502988 scopus 로고    scopus 로고
    • Under use of aspirin in type 2 diabetes mellitus: Prevalence and correlates of therapy in rural Canada
    • Klinke JA, Johnson JA, Guirguis LM, et al. Under use of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada. Clin Ther 2004;26:439-446.
    • (2004) Clin Ther , vol.26 , pp. 439-446
    • Klinke, J.A.1    Johnson, J.A.2    Guirguis, L.M.3
  • 5
    • 10344249915 scopus 로고    scopus 로고
    • Aspirin use among adults with diabetes: Recent trends and emerging sex disparities
    • Persell SD, Baker DW. Aspirin use among adults with diabetes: recent trends and emerging sex disparities. Arch Intern Med 2004;164:2492- 2499.
    • (2004) Arch Intern Med , vol.164 , pp. 2492-2499
    • Persell, S.D.1    Baker, D.W.2
  • 6
    • 0036546233 scopus 로고    scopus 로고
    • Control of cardiovascular risk factors in patients with diabetes and hypertension at Urban Academic Medical Centers
    • McFarlane SI, Jacober SJ, Winer N, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at Urban Academic Medical Centers. Diabetes Care 2002;25:718-723.
    • (2002) Diabetes Care , vol.25 , pp. 718-723
    • McFarlane, S.I.1    Jacober, S.J.2    Winer, N.3
  • 7
    • 0035140649 scopus 로고    scopus 로고
    • Aspirin use among adults with diabetes. Estimates from the third National Health and Nutrition Examination survey
    • Rolka DB, Fagot-Campagna N, Narayan KMV. Aspirin use among adults with diabetes. Estimates from the third National Health and Nutrition Examination survey. Diabetes Care 2001;24:197-201.
    • (2001) Diabetes Care , vol.24 , pp. 197-201
    • Rolka, D.B.1    Fagot-Campagna, N.2    Narayan, K.M.V.3
  • 8
    • 0141781127 scopus 로고    scopus 로고
    • Decisional attributes of patients with diabetes: The aspirin choice
    • Montori VM, Bryant SC, O'Connor AM, et al. Decisional attributes of patients with diabetes: the aspirin choice. Diabetes Care 2003;26: 2804-2809.
    • (2003) Diabetes Care , vol.26 , pp. 2804-2809
    • Montori, V.M.1    Bryant, S.C.2    O'Connor, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.